AbCellera Biologics Inc. Common Shares vs. Eli Lilly & Co.
AbCellera Biologics Inc. Common Shares and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABCL | LLY | |
|---|---|---|
| Market Cap | $3.98 billion | $1.21 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| ABCL | LLY | |
|---|---|---|
| Dividend Yield | — | 0.49% |
ABCL and LLY split the dividend factors evenly.
Risk & Sentiment
| ABCL | LLY | |
|---|---|---|
| Short Interest | 0.31% | 1.29% |
ABCL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABCL overview, ABCL financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.